Tag: Hims
Hims & Novo Call a Truce, Hims Gets Exactly What It Wanted
Novo Nordisk and Hims & Hers have come to a mutual agreement, choosing collaboration over conflict by dropping…
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
Shares of Hims & Hers Health (NYSE: HIMS) experienced a significant surge in value following an agreement with…
Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary
Hims & Hers Health, Inc. recently conducted their Q4 2025 Earnings Call, where management highlighted their transition towards…
Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises
Domino's (DPZ) Reports Mixed Fourth Quarter and Fiscal 2025 Results Domino's (DPZ) recently announced its fourth quarter and…
As Hims & Hers Gets Hit With Major Wegovy Loss, Should You Buy the Dip in Deeply Oversold HIMS Stock?
Hims & Hers (HIMS) stock has taken a significant hit, dropping more than 25% in recent sessions due…
Vaccines, Hims, gender affirming care: Morning Rounds
The American Medical Association's Stance on Gender-Affirming Surgery for Minors Recent statements made by the American Medical Association…
Hims & Hers won’t sell compounded version of Novo’s obesity pill
Hims & Hers made a controversial decision to stop selling a compounded version of Novo Nordisk’s obesity pill…
Hims & Hers Super Bowl Ad To Spotlight The Health-Wealth Gap
Hims & Hers Makes Bold Statement About Health-Wealth Gap in New Super Bowl Ad In a move to…
Is Hims & Hers Health a Smart Buy Right Now?
Hims & Hers: The Telemedicine Disruptor Making Waves Hims & Hers is making a big splash in the…
Is the GLP-1 party running down for Hims, and a study for the weekend
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your…